News Focus
News Focus
icon url

BullionNation

10/27/10 9:13 AM

#151 RE: BioSpecialist #150

I agree, but I think FDA Approval sends this much higher than $5.00-$7.00.
This just needs much more awareness. Chart is ALMOST primed for a nice little breakout again, just need to cross $2.25 and then $2.53 and I think we can pop again.
icon url

BullionNation

10/27/10 9:15 AM

#152 RE: BioSpecialist #150

Yesterday's news should have run this to $3.00-$3.50. Approaching other cancers besides just prostate, is absolutely huge for the company. Our only problem is that nobody follows this stock.

Perhaps we get a delayed response from the news yesterday and run today.
icon url

BioSpecialist

10/28/10 3:29 AM

#153 RE: BioSpecialist #150

Honestly, after reading and seeing that, you would have to be nuts to sell EDAP stock below 10 dollar. This company has nowhere to go but up.

I strongly suggest any new investor visit the EDAP website found here:

Ablatherm HIFU for Prostate Cancer Treatment by EDAP VIDEO



EDAP Received Significant Visibility for Ablatherm-HIFU at American Urological Association Annual Meeting
Read more: http://www.nasdaq.com/aspx/company-news-story.aspx?storyid=201006081322primzoneusprx___193812&title=edap-received-significant-visibility-for-ablatherm-hifu-at-american-urological-association-annual-meeting#ixzz13dTKvJZj



Power Of Sound Gives Cancer Victims Hope
http://news.sky.com/skynews/Home/UK-News/Ultrasound-Used-To-Fight-Prostate-Cancer-In-Trials-At-North-Hampshire-Hospital-In-Basingstoke/Article/200906215298901?lpos=UK_News_First_Home_Article_Teaser_Region_9&lid=ARTICLE_15298901_Ultrasound_Used_To_Fight_Prostate_Cancer_In_Trials_At_North_Hampshire_Hospital_In_Basingstoke


Ablatherm® HIFU Prostate Cancer Treatment a Safe Alternative
to Surgery or Radiotherapy
http://www.hifu.ca/news/prostate-surgery-alternative.php


Media Coverage (Great Links)
http://investor.edap-tms.com/placements.cfm





EDAP IT"S "THE REAL THING".
icon url

BioSpecialist

11/24/10 6:33 AM

#224 RE: BioSpecialist #150

Approval is coming

edap is still massive undervalued .